Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
2.850
+0.090 (3.26%)
Jun 29, 2026, 9:37 AM EDT - Market open
Fortress Biotech Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Fortress Biotech stock have an average target of 11, with a low estimate of 5.00 and a high estimate of 17. The average target predicts an increase of 285.96% from the current stock price of 2.85.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 18, 2026.
Analyst Ratings
The average analyst rating for Fortress Biotech stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Buy Maintains $4.5 → $5 | Buy | Maintains | $4.5 → $5 | +75.44% | May 18, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $17 | Buy | Reiterates | $17 | +496.49% | Feb 23, 2026 |
Financial Forecast
Revenue This Year
79.88M
from 63.26M
Increased by 26.26%
Revenue Next Year
134.15M
from 79.88M
Increased by 67.95%
EPS This Year
-0.40
EPS Next Year
18.60
from -0.40
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 79.9M | 145.3M | |
| Avg | 79.9M | 134.2M | |
| Low | 79.9M | 123.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 26.3% | 81.9% | |
| Avg | 26.3% | 67.9% | |
| Low | 26.3% | 54.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.40 | 18.60 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.